- Home
- SAGE vs USNA Comparison
SAGE vs USNA Comparison
Compare SAGE & USNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SAGE
- USNA
- Stock Information
- Founded
- SAGE 2010
- USNA 1992
- Country
- SAGE United States
- USNA United States
- Employees
- SAGE N/A
- USNA N/A
- Industry
- SAGE Biotechnology: Pharmaceutical Preparations
- USNA Medicinal Chemicals and Botanical Products
- Sector
- SAGE Health Care
- USNA Health Care
- Exchange
- SAGE Nasdaq
- USNA Nasdaq
- Market Cap
- SAGE 571.7M
- USNA 565.2M
- IPO Year
- SAGE 2014
- USNA 1996
- Fundamental
- Price
- SAGE $9.08
- USNA $32.48
- Analyst Decision
- SAGE Hold
- USNA Hold
- Analyst Count
- SAGE 18
- USNA 1
- Target Price
- SAGE $10.06
- USNA $36.00
- AVG Volume (30 Days)
- SAGE 2.8M
- USNA 156.9K
- Earning Date
- SAGE 07-30-2025
- USNA 07-22-2025
- Dividend Yield
- SAGE N/A
- USNA N/A
- EPS Growth
- SAGE N/A
- USNA N/A
- EPS
- SAGE N/A
- USNA 1.82
- Revenue
- SAGE $47,404,000.00
- USNA $876,242,000.00
- Revenue This Year
- SAGE $102.21
- USNA $13.04
- Revenue Next Year
- SAGE $43.01
- USNA $7.36
- P/E Ratio
- SAGE N/A
- USNA $17.77
- Revenue Growth
- SAGE N/A
- USNA N/A
- 52 Week Low
- SAGE $4.62
- USNA $23.10
- 52 Week High
- SAGE $13.47
- USNA $48.85
- Technical
- Relative Strength Index (RSI)
- SAGE 71.54
- USNA 66.84
- Support Level
- SAGE $9.04
- USNA $30.36
- Resistance Level
- SAGE $9.30
- USNA $31.43
- Average True Range (ATR)
- SAGE 0.15
- USNA 0.82
- MACD
- SAGE 0.05
- USNA 0.13
- Stochastic Oscillator
- SAGE 91.35
- USNA 100.00
About SAGE Sage Therapeutics Inc.
Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on brain health medicines. The company is targeting diseases and disorders of the brain with three key focus areas: depression, neurology and neuropsychiatry; also targeting two critical central nervous system, or CNS, receptor systems, GABA and NMDA. Its products ZURZUVAE is a medicine for the treatment of postpartum depression, or PPD, in adults, and ZULRESSO is a CIV injection for the treatment of postpartum depression in individuals 15 years old and older. It also has other drugs in its pipeline such as SAGE-324, Dalzanemdor (SAGE-718) among others.
About USNA USANA Health Sciences Inc.
Usana Health Sciences Inc is a direct selling and direct-to-consumer nutrition, personal health and wellness company. It developed and manufactured science-based nutritional, personal care and skincare products with a focus on promoting long-term health and wellness. The company has two reportable segments: direct selling and Hiya direct-to-consumer. The direct selling segment develops and manufactures high quality, science-based nutritional, personal care and skincare products with a focus on promoting long-term health and wellness in various geographic markets that are distributed through the direct selling channel. The Hiya direct-to-consumer segment is a provider of children's health and wellness products in the U.S. Key revenue is generated from Direct selling segment.